AIR (Asia Investor Relations) held its inaugural Investor Forum in Singapore, convening pre-IPO investors, issuers, and capital markets practitioners in a structured session focused on IPO readiness, portfolio diversification through pre-IPO allocation, and early-stage engagement ahead of potential U.S. listings.

Boustead APEX, Inc., Raffles Capital, and Asia Investor Relations (AIR), opened Season II of the IPO Conference (IPOC) series in Singapore on 9 April, marking the 2026 kick-off of a multi-city program focused on U.S. IPO readiness and investor engagement for Asia-based issuers.

AIR (Asia Investor Relations) has concluded a landmark investor engagement program across New York and Boca Raton, bringing together seven growth-stage issuers and one fund in a structured pathway toward potential US public listing within 18–24 months under a bespoke execution framework led by Boustead APEX, Inc..

Shift from Nasdaq to OTCQX—community banks and midcap issuers—can be understood as a strategic trade-off between regulatory burden, cost efficiency, and market accessibility

Expanded two-day format designed to bridge ambitious founders with institutional and private investors seeking the next generation of public-market leaders.

An investor relations and capital markets advisory platform, with a mission to connect high-growth Asian companies with global investors and US public markets.

EWC Indo-Pacific Winners & Global Top 250 Alumni from IPO Conference

Dr. Charlie In discusses the evolving landscape of impact investing and the opportunities for channeling capital toward the Sustainable Development Goals (SDGs).

Boustead APEX CEO Dr. Marcuz Tan discusses the growing trend of Asian companies listing on U.S. exchanges and the strategic considerations behind these moves.

Four High-Potential Asian Companies Chosen for U.S. IPO Pathway

Three companies selected for U.S. IPO pathway under Boustead APEX, Inc. & Raffles Capital

Boustead APEX, Inc. and Raffles Capital engaged in an insightful fire-side chat during Try Everything 2025.

Boustead APEX, Inc., Asia’s leading U.S. IPO advisory firm, together with its strategic partners including the China Centre for Promoting SME Cooperation and Development (中小企业合作发展促进中心) and international law firm Loeb & Loeb LLP, has successfully completed several major stops of its inaugural China Multi-City IPO Conference including Shenzhen, Beijing, and Shanghai.

Boustead APEX, Inc., in collaboration with international law firm Loeb & Loeb LLP, successfully hosted the Beijing stop of its China-wide IPO Conference series.

Regen Health Care Group, a leading provider of advanced stem cell regeneration therapies, announced today its strategic partnership with Boustead APEX, Inc., Boustead & Co, and cornerstone investor Raffles Capital US to bring the company public in the United States.

Emperor Tea has announced plans to pursue an Initial Public Offering (IPO) in the United States, a major step in its mission to globalise its brand — including entering the U.S. market — and bring the natural herbal goodness of tea to consumers worldwide. The company will be advised by Boustead APEX, Inc.

Boustead APEX, Inc., in partnership with Wan Yi Group, successfully hosted the 2nd Shenzhen IPO Conference (IPOC), attracting over 80 high-growth companies from Shenzhen eager to explore opportunities in the U.S. capital markets. The event brought together leading experts, underwriters, investors, and legal professionals to discuss how Asian companies can efficiently list and thrive on the NYSE and NASDAQ.

Boustead APEX, Inc. kicked off its inaugural China-wide IPO Conference in Shenzhen, the first of multiple city stops that will also include Beijing, Shanghai, and Hangzhou, bringing together entrepreneurs, investors, and market experts to share strategies for profitable growth and stronger positioning for U.S. capital market listings — while preserving founder equity.

Raffles Capital Pte. Ltd. (“RC”) and Raffles Financial Group Limited (“RFG”) issue this official statement in response to recent incidents of false advertising and misrepresentation.

IPO Conference - Asia Edition 2025: Empowering Asia’s Next Generation of Public Companies
BAI is spearheading the IPO Conference - Asia Edition 2025, a landmark event series designed to demystify the IPO journey for Asia-Pacific businesses.